AstraZeneca Launches New Crestor DTC Ad Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm is managing the right level of investment for Crestor, CFO Symonds tells analysts. The statin has a 7.6% share of new prescriptions for the week ending Oct. 8.